Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108003 · ClinicalTrials.gov registry record · NA
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01108003 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 7 participants.
The verdict
NCT01108003, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Rationale: Broccoli sprout extract contains ingredients that may prevent or slow the growth of certain cancers. Purpose: This pilot study is studying the side effects of broccoli sprout extract in treating patients with transitional cell bladder cancer undergoing surgery.
Interventions
- OTHER laboratory biomarker analysis
- DRUG broccoli sprout extract
- OTHER Mango Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01108003
The ClinicalTrials.gov registry entry for NCT01108003 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01108003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01108003 about?
NCT01108003 is a clinical study titled "Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery". Rationale: Broccoli sprout extract contains ingredients that may prevent or slow the growth of certain cancers. Purpose: This pilot study is studying the side effects of broccoli sprout extract in treating patients with transitional cell bladder cancer undergoing surgery.
What is the current status of trial NCT01108003?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2010-04. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01108003?
The interventions under investigation include: laboratory biomarker analysis (OTHER), broccoli sprout extract (DRUG), Mango Juice (OTHER).
Who is sponsoring clinical trial NCT01108003?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.